Correlation Between Edgewise Therapeutics and Precigen

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Edgewise Therapeutics and Precigen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Edgewise Therapeutics and Precigen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Edgewise Therapeutics and Precigen, you can compare the effects of market volatilities on Edgewise Therapeutics and Precigen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Edgewise Therapeutics with a short position of Precigen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Edgewise Therapeutics and Precigen.

Diversification Opportunities for Edgewise Therapeutics and Precigen

-0.62
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Edgewise and Precigen is -0.62. Overlapping area represents the amount of risk that can be diversified away by holding Edgewise Therapeutics and Precigen in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Precigen and Edgewise Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Edgewise Therapeutics are associated (or correlated) with Precigen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Precigen has no effect on the direction of Edgewise Therapeutics i.e., Edgewise Therapeutics and Precigen go up and down completely randomly.

Pair Corralation between Edgewise Therapeutics and Precigen

Given the investment horizon of 90 days Edgewise Therapeutics is expected to under-perform the Precigen. But the stock apears to be less risky and, when comparing its historical volatility, Edgewise Therapeutics is 1.9 times less risky than Precigen. The stock trades about -0.05 of its potential returns per unit of risk. The Precigen is currently generating about 0.15 of returns per unit of risk over similar time horizon. If you would invest  82.00  in Precigen on September 2, 2024 and sell it today you would earn a total of  11.00  from holding Precigen or generate 13.41% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Edgewise Therapeutics  vs.  Precigen

 Performance 
       Timeline  
Edgewise Therapeutics 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Edgewise Therapeutics are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Edgewise Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.
Precigen 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Precigen has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unsteady performance, the Stock's technical and fundamental indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

Edgewise Therapeutics and Precigen Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Edgewise Therapeutics and Precigen

The main advantage of trading using opposite Edgewise Therapeutics and Precigen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Edgewise Therapeutics position performs unexpectedly, Precigen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Precigen will offset losses from the drop in Precigen's long position.
The idea behind Edgewise Therapeutics and Precigen pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Other Complementary Tools

Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios